Results 21 to 30 of about 1,472,301 (348)
Nature Medicine, 2022 Previous studies have suggested that the gut microbiome influences the response to checkpoint inhibitors (CPIs) in patients with cancer. CBM588 is a bifidogenic live bacterial product that we postulated could augment CPI response through modulation of ...
N. Dizman +26 more
semanticscholar +1 more source
Simultaneous Chromophobe renal cell carcinoma and squamous renal cell carcinoma
Diagnostic Pathology, 2007 Chromophobe renal cell carcinoma (CHRC) is a neoplasm of the kidney with clinicopathologic peculiarities that seems to be of better prognosis than conventional renal cell carcinoma.
Robles Luis +4 more
doaj +1 more source
Radiogenomics in clear cell renal cell carcinoma: correlations between advanced CT imaging (texture analysis) and microRNAs expression [PDF]
, 2019 Purpose: A relevant challenge for the improvement of clear cell renal cell carcinoma management could derive from the identification of novel molecular biomarkers that could greatly improve the diagnosis, prognosis, and treatment choice of these ...
Badia, S. +12 more
core +1 more source
World Journal of Urology, 2016 Renal cell cancer (RCC) accounts for approximately 2–3 % of all human malignancies and shows a worldwide increase of incidence rate of 2 % per year [1]. It primarily affects men and women at the age of 50–70 years with a twofold higher incidence rate in men.
Axel S, Merseburger +2 more
openaire +2 more sources
Urology Case Reports, 2018 Clear cell renal cell carcinoma and papillary renal cell carcinoma are the most common types of renal tumors. However, coexistence of both tumors in the same kidney is a rare condition.We report a 56-year old male who was found to have ipsilateral ...
Muna Alhusban +3 more
doaj +1 more source
Effects of phlebotomy on the growth of ferric nitrilotriacetate-induced renal cell carcinoma. [PDF]
, 2002 The ferric nitrilotriacetate-induced carcinogenesis model is unique in that reactive oxygen species-free radicals are involved in the carcinogenic process.
Fujisawa, Masayoshi +5 more
core +1 more source
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal‐Cell Carcinoma
New England Journal of Medicine, 2019 BACKGROUND The combination of pembrolizumab and axitinib showed antitumor activity in a phase 1b trial involving patients with previously untreated advanced renal‐cell carcinoma.
B. Rini +26 more
semanticscholar +1 more source
Metastatic renal cell carcinoma presenting as a paranasal sinus mass: the importance of differential diagnosis [PDF]
, 2017 Metastases in the paranasal sinuses are rare; renal cell carcinoma is the most common cancer that metastasizes to this region. We present the case of a patient with a 4-month history of a rapidly growing mass of the nasal pyramid following a nasal trauma,
ALTISSIMI, Giancarlo +3 more
core +4 more sources
Clear Cell Renal Cell Carcinoma: From Biology to Treatment
Cancers, 2023 Simple Summary Over the past two decades, biological discoveries have transformed the treatment strategies for renal cell carcinoma. These advances have led to the development of agents targeting pro-angiogenic pathways and the immunogenicity of renal ...
A. Kase, D. George, Sundhar Ramalingam
semanticscholar +1 more source
Synchronous bilateral renal cell carcinomas with differing histologies
IJU Case Reports, 2020 Introduction Bilateral renal cell carcinomas with different histological types are rare. We report herein the first description of bilateral renal carcinomas with clear cell renal cell carcinoma and mucinous tubular and spindle cell carcinoma occurring ...
Ryu Shigehisa +9 more
doaj +1 more source